HealthQuill Biogen
Japan’s Eisai Co., and US-based Biogen Inc., announced its Leqembi injection will be sold in Japan from Japan from December 20, the second country after the US.
Drugs Health Pharma

Eisai, Biogen to sell Alzheimer’s drug in Japan starting December 20 

HQ Team December 13, 2023: Japan’s Eisai Co., and US-based Biogen Inc., announced its Leqembi injection will be sold in Japan from Japan.

Read More
Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimer’s disease and cognitive impairment has been approved in Japan.
Drugs Health Pharma

Japan approves Eisai Co, Biogen Inc’s Leqembi for Alzheimer’s 

HQ Team September 25, 2023: Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimer’s disease and cognitive impairment has been.

Read More
The USFDA has green-lighted the first oral medication indicated to treat postpartum depression in women, which occurs after childbirth or during the later stages of pregnancy.
Drugs Health Pharma

FDA clears first oral drug to treat postpartum depression or ‘baby blues’

HQ Team August 5, 2023: The USFDA has green-lighted the first oral medication indicated to treat postpartum depression in women, which occurs after.

Read More
The USFDA has granted a standard approval for Eisai and Biogen's Alzheimer injection, Leqembi —the first treatment to secure the traditional approval, paving the way for wider insurance coverage of the drug.
Drugs Health Pharma

USFDA grants green light to Eisai, Biogen’s Alzheimer’s drug Leqembi

HQ Team July 7, 2023: The USFDA has granted a standard approval for Eisai and Biogen’s Alzheimer injection, Leqembi —the first treatment to secure the.

Read More